Currently out of the existing stock ratings of Stan Berenshteyn, 17 are a BUY (37.78%), 4 are a SELL (8.89%), 24 are a HOLD (53.33%).

Stan Berenshteyn

Work Performance Price Targets & Ratings Chart

Analyst Stan Berenshteyn works at WELLS FARGO with a stock forecast success ratio of 64.48% fulfilled within 54.75 days on average.

Stan Berenshteyn’s has documented 91 price targets and ratings displayed on 8 stocks. The coverage is on the Healthcare sector.

Most recent stock forecast was given on HCAT, Health Catalyst at 10-May-2024.

Wall Street Analyst Stan Berenshteyn

Analyst best performing recommendations are on ACCD (ACCOLADE ).
The best stock recommendation documented was for GDRX (GOODRX HOLDINGS ) at 8/10/2023. The price target of $7 was fulfilled within 7 days with a profit of $1.25 (15.15%) receiving and performance score of 21.65.

Average potential price target upside

OMCL Omnicell ACCD Accolade  GDRX Goodrx Holdings  HQY HealthEquity DOCS Doximity HCAT Health Catalyst TDOC Teladoc VEEV Veeva Systems

Analyst name

Rating

Current price target

Potential Upside

Previous price target

Date

Price targets met ratio

Average potential upside

Average Time (Days) For PT To Be Met

Performance score

Buy

38

$7.56 (24.84%)

38

15 days ago

7/15 (46.67%)

$7.87 (26.12%)

107

Hold

26

$-4.44 (-14.59%)

39

3 months 9 days ago

5/9 (55.56%)

$-1.41 (-5.14%)

80

Hold

28

$-2.44 (-8.02%)

59

6 months 12 days ago

4/4 (100%)

$-1.51 (-5.12%)

68

Buy

39

$8.56 (28.12%)

66

6 months 15 days ago

13/18 (72.22%)

$8.56 (28.12%)

113

Hold

75

6 months 15 days ago

3/7 (42.86%)

$21.12 (39.20%)

151

Show more analysts

To gain access for the analyst/ stock price target chart please use a computer

Which stock is Stan Berenshteyn is most bullish on?

Potential upside of $13.79 has been obtained for HQY (HEALTHEQUITY)

Which stock is Stan Berenshteyn is most reserved on?

Potential downside of -$4.44 has been obtained for OMCL (OMNICELL)

What Year was the first public recommendation made by Stan Berenshteyn?

On 2021

To continue looking at which analysts cover the stock please register to the basic or advanced membership

What is AnaChart?